Evidence map›Paper›PMID 37511203›Full record

ArticleInternational journal of molecular sciences2023

Myocardial Infarction Susceptibility and the

Ivana Škrlec, Zrinka Biloglav, Jasminka Talapko, Snježana Džijan, Danijela Daus-Šebeđak, Vera Cesar

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. Association ofInternational journal of molecular sciences · 2025
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Ivana ŠkrlecFaculty of Dental Medicine and Health, Josip Juraj Strossmayer University of Osijek, 31000 Osijek, Croatia.ORCID 0000-0003-1842-930X
Zrinka BiloglavDepartment of Medical Statistics, Epidemiology and Medical Informatics, School of Public Health Andrija Štampar, 10000 Zagreb, Croatia.
Jasminka TalapkoFaculty of Dental Medicine and Health, Josip Juraj Strossmayer University of Osijek, 31000 Osijek, Croatia.ORCID 0000-0001-5957-0807
Snježana DžijanFaculty of Dental Medicine and Health, Josip Juraj Strossmayer University of Osijek, 31000 Osijek, Croatia.
Danijela Daus-ŠebeđakFamily Medicine Practice 'Dr. Danijela Daus-Šebeđak', 35107 Podvinje, Croatia.
Vera CesarFaculty of Dental Medicine and Health, Josip Juraj Strossmayer University of Osijek, 31000 Osijek, Croatia.
University of Osijek · HRGenos (Croatia) · HRUniversity of Zagreb · HR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Melatonin is a circadian hormone with antioxidant properties that protects against myocardial ischemia-reperfusion injury. Genetic variations of the melatonin receptor 1B gene (

Indexed as

Diabetes Mellitus, Type 2Myocardial InfarctionReceptor, Melatonin, MT2Case-Control StudiesFemaleGenetic Predisposition to DiseaseGenotypeHumansMalePolymorphism, GeneticPolymorphism, Single NucleotideRisk FactorsMTNR1B protein, humanReceptor, Melatonin, MT2cardiovascular diseasesmelatonin receptorMTNR1Bmyocardial infarction

Identifiers

PMID37511203
PMCPMC10380655
OpenAlexW4384339153

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.